Delivery Order SPE2DX22D0099-SPE2D825FAR1E
- Not listed
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a firm fixed price delivery order valued at $15,886.02 to AmerisourceBergen Drug Corp (CAGE 0U9U0) on August 16, 2025, with an ultimate completion date of August 18, 2025. This non-set-aside contract represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The delivery order will...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $22,117.71 on August 25, 2025, by the Defense Logistics Agency's Medical Supply Chain. The contract, designated as a firm fixed price delivery order with no set-aside provision, carries an ultimate completion date of August 26, 2025, and represents a competitively awarded procurement. This delivery order is a child contract under...
- This delivery order, valued at $17,143.05, was awarded to AmerisourceBergen Drug Corp on August 12, 2025, by the Defense Logistics Agency's Medical Supply Chain division under a firm fixed-price contract structure. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The place of performance is located in Conshohocken, Pennsylvania, the...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $31,129.52 by the Defense Logistics Agency's Medical Supply Chain on August 2, 2025. This firm fixed-price delivery order, which has an ultimate completion date of August 4, 2025, was competitively awarded with no set-aside designation. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $10,806.66 to AmerisourceBergen Drug Corp (CAGE 0U9U0) on August 11, 2025, with an ultimate completion date of August 12, 2025. This firm fixed-price, competitively awarded delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.999 billion through December 2026. The contract involves...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $14,662.80 to AmerisourceBergen Drug Corp (CAGE 0U9U0) on August 11, 2025, with an ultimate completion date of August 12, 2025. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The delivery order was competitively awarded with...
- The Defense Logistics Agency Medical Supply Chain awarded a $11,606.40 delivery order to AmerisourceBergen Drug Corp (CAGE 0U9U0) on July 21, 2025, with an ultimate completion date of July 22, 2025. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The award was made through open competition with no set-aside designation, and...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $10,521.51 by the Defense Logistics Agency's Medical Supply Chain on August 20, 2025. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. The contract carries no set-aside designation and was competitively awarded. Performance will be...
- This delivery order, valued at $23,174.73, was awarded on August 18, 2025, to AmerisourceBergen Drug Corp, a leading pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. The contract is a firm fixed price delivery order with an ultimate completion date of August 19, 2025, and represents a non-set-aside award. The funding agency is the Defense Logistics Agency's Medical Supply Chain, which procures critical pharmaceutical and medical supplies for Department of Defense...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $14,173.80 to AmerisourceBergen Drug Corp (CAGE 0U9U0) on August 20, 2025, with an ultimate completion date of August 21, 2025. This non-competitive, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $1 billion vehicle running through December 2026 that serves as the company's primary vehicle...
- SPE2DX22D0099Indefinite Delivery Contract
- SPE2DX22D0099-SPE2D825FAR1EDelivery Order
This delivery order, valued at $10,181.21, was awarded on August 18, 2025, to AmerisourceBergen Drug Corp (CAGE: 0U9U0) by the Defense Logistics Agency's Medical Supply Chain division. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.999 billion comprehensive pharmaceutical support vehicle running through December 2026. This delivery order is a firm fixed-price, non-set-aside award with an ultimate completion date of August 19, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor that serves as a critical federal healthcare vendor, particularly for military and veteran healthcare systems. The company's extensive federal contract portfolio demonstrates its capability to supply a comprehensive range of pharmaceutical products and medical supplies, including brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities. As a competitively awarded contractor on the DLA's global pharmaceutical program, AmerisourceBergen supports multiple federal customers including the Defense Health Agency and U.S. Coast Guard, fulfilling diverse medical supply requirements across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.2k | 8/18/25 |